author-photo

Yong S. Chang

Bayer HealthCare Pharmaceuticals

10

Papers

724

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Targeting the Insulin-like Growth Factor Axis for the Development of Novel Therapeutics in Oncology

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (83)
Therapeutic Mechanism and Efficacy of the Antibody Drug-Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9

2012 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (43)
Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growth.

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (98)
100 Inhibition of PDGFRalpha in tumor stroma with MEDI-575 enhances activity of carboplatin/paclitaxel and delays tumor regrowth in a NSCLC xenograft model

2010 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
57 Glioblastoma multiforme is characterized by high incidence of PDGFRalpha expression and susceptibility to the PDGFRalphaspecific antibody MEDI-575 in mouse tumor models

2010 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
Antitumor activity of sorafenib in FLT3-driven leukemic cells

2007 Leukemia
Show All
- Source
- Cite
- Save
Citations (141)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models

2007 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (357)
148 BAY 57-9352: an inhibitor of VEGFR-2 and PDGFR receptor tyrosine kinases that demonstrates broad anti-tumor activity as a single agent in preclinical models

2004 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (2)